Acute Guillain–Barré syndrome during the chronic phase of HIV infection and dramatic improvement under highly active antiretroviral therapy

Bani‐Sadr, Firouzé; Neuville, Ségolène; Guihot, Amélie; Molina, Jean Michel

doi:10.1097/00002030-200207260-00017

Cited by 14 publications

(5 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Brannagan et al (4) evaluated 10 HIV (+) -GBS cases and found that HIV diagnosis of 3 cases was verified in the ICU. One of these cases with an initial CD4 count of 175x10 6 cells L -1 in the ICU, died due to cardiac reasons. The first CD4 count of our patient in the ICU was 71x10 6 cells L -1 and he died of complications secondary to sepsis.…”

Section: Discussionmentioning

confidence: 99%

Guillain-Barré Syndrome and Human Immunodeficiency Virus

Girgin¹,

İşçimen²,

Yılmaz³

et al. 2014

Turk J Anesth Reanim

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Guillain-Barré Syndrome and Human Immunodeficiency Virus

Girgin¹,

İşçimen²,

Yılmaz³

et al. 2014

Turk J Anesth Reanim

View full text Add to dashboard Cite

“…In other cases, however, patients continued to have relapses despite treatment. From the 42 reviewed cases of ART-naïve patients with GBS, the outcomes varied regardless of which treatment was provided, as demonstrated in Table 1 [9,11,13,15,19,20,[23][24][25][26][27][28][29][30][31][32][33][34][35][36][37]. ART is linked to both the relapse of AIDP upon its discontinuation as well as the cause of AIDP due to drug side-effects and/or IRIS [35].…”

Section: Role Of Art In the Treatment Of Hiv-associated Idpmentioning

confidence: 99%

Treatment Challenges for Inflammatory Demyelinating Polyneuropathy in the Setting of Acute Retroviral Syndrome: Case Report and Review of the Literature

et al. 2013

View full text Add to dashboard Cite

This is a case of a 20-year-old male with acute retroviral syndrome and concurrent acute inflammatory demyelinating polyneuropathy (IDP) progressing to chronic IDP. Whereas the patient followed a relapsing and remitting course prior to the initiation of antiretroviral therapy (ART), he demonstrated gradual and sustained clinical improvement in the ten months of follow-up after ART was combined with chronic corticosteroids and intermittent plasmapheresis. This case presents and addresses multiple challenges for the treatment of IDP in the setting of acute HIV infection to include: timing of initiation and selection of appropriate ART, the potential risk for immune reconstitution inflammatory syndrome, ART initiation in the setting of severe gastroparesis with jejunostomy placement, and the effect of plasmapheresis on the levels of antiretroviral therapy. J o ur nal o f A ID S & Cli n ic a l R es earc h

show abstract

“…29,40,42 In terms of treatment, there has been one report of complete resolution of symptoms after initiation of cART only. 46 However, most report management of GBS and CIDP in HIV as no different than in HIVnegative individuals using intravenous immunoglobulin (IVIg), plasma exchange, and supportive care. 29,42,43 Corticosteroids are not absolutely contraindicated for HIV-associated CIDP, but should be used with caution.…”

Section: Inflammatory Demyelinating Polyneuropathymentioning

confidence: 99%

Atypical Nervous System Manifestations of HIV

2011

View full text Add to dashboard Cite

Despite the widespread success of combination antiretroviral therapy (cART) in reducing morbidity and mortality in human immunodeficiency virus 1 (HIV-1) infection, HIV-associated neurologic disease remains prevalent. Although the virus is unable to infect neurons or muscle fibers directly, it can still injure these structures by a variety of mechanisms, many of which are yet to be elucidated. Additionally, antiretroviral medications used to treat HIV infection can cause damage to the nervous system both by direct toxicity and via modulation of host-virus interactions. Some neurologic complications of HIV infection are rarely seen and are poorly understood; nevertheless, they are important to recognize. In this review article, the authors focus on the uncommon neurologic manifestations of HIV infection, including mononeuropathies, inflammatory demyelinating polyneuropathies, motor neuron disease, polymyositis, diffuse infiltrative lymphocytosis syndrome, mononeuritis multiplex, HIV-associated neuromuscular weakness syndrome, immune reconstitution inflammatory syndrome, and central nervous system HIV-escape meningoencephalomyelitis and myelitis.

show abstract

Acute Guillain–Barré syndrome during the chronic phase of HIV infection and dramatic improvement under highly active antiretroviral therapy

Cited by 14 publications

References 5 publications

Guillain-Barré Syndrome and Human Immunodeficiency Virus

Guillain-Barré Syndrome and Human Immunodeficiency Virus

Treatment Challenges for Inflammatory Demyelinating Polyneuropathy in the Setting of Acute Retroviral Syndrome: Case Report and Review of the Literature

Atypical Nervous System Manifestations of HIV

Contact Info

Product

Resources

About